P-Cox

P-Cox: anti-tuberculosis drug from India

Pi-Cox is an anti-tuberculosis drug produced by the Indian pharmaceutical company Dii-Pharma. The active substance in Pi-Cox is pyrazinamide, which belongs to the group of anti-tuberculosis drugs of different chemical groups.

Pyrazinamide is widely used to treat tuberculosis, including in combination with other anti-tuberculosis drugs. It can be prescribed both to treat active tuberculosis and to prevent relapses.

P-Cox is available in the form of tablets that contain 500 mg or 700 mg pyrazinamide. To treat tuberculosis, a combination of several anti-tuberculosis drugs, including Pi-Cox, is usually prescribed.

Like all medications, Pi-Cox has some contraindications. The drug is not recommended in case of hypersensitivity to its components, impaired liver function and acute gout. In addition, the use of Pi-Cox can cause a number of side effects, such as allergic reactions, liver damage, increased serum iron concentrations, arthralgia, myalgia, dyspeptic symptoms, etc.

The interaction of P-Cox with other drugs may also be an important factor in the treatment of tuberculosis. The use of Pi-Cox may enhance the effects of other anti-tuberculosis drugs and reduce the effectiveness of anti-gout drugs.

Although P-Cox was published in the literature in 2004, the drug remains an important drug for the treatment of tuberculosis. It is widely used in various countries including India where it is produced.

In conclusion, P-Cox is an important drug for the treatment of tuberculosis manufactured in India by Dii-Pharma. It is available in tablet form and contains the active substance pyrazinamide. Also, like other drugs, Pi-Cox has some contraindications and side effects, and its interaction with other drugs must be taken into account when prescribing therapy.